» Articles » PMID: 25155877

Glutathione Deficit Impairs Myelin Maturation: Relevance for White Matter Integrity in Schizophrenia Patients

Overview
Journal Mol Psychiatry
Date 2014 Aug 27
PMID 25155877
Citations 60
Authors
Affiliations
Soon will be listed here.
Abstract

Schizophrenia pathophysiology implies both abnormal redox control and dysconnectivity of the prefrontal cortex, partly related to oligodendrocyte and myelin impairments. As oligodendrocytes are highly vulnerable to altered redox state, we investigated the interplay between glutathione and myelin. In control subjects, multimodal brain imaging revealed a positive association between medial prefrontal glutathione levels and both white matter integrity and resting-state functional connectivity along the cingulum bundle. In early psychosis patients, only white matter integrity was correlated with glutathione levels. On the other side, in the prefrontal cortex of peripubertal mice with genetically impaired glutathione synthesis, mature oligodendrocyte numbers, as well as myelin markers, were decreased. At the molecular levels, under glutathione-deficit conditions induced by short hairpin RNA targeting the key glutathione synthesis enzyme, oligodendrocyte progenitors showed a decreased proliferation mediated by an upregulation of Fyn kinase activity, reversed by either the antioxidant N-acetylcysteine or Fyn kinase inhibitors. In addition, oligodendrocyte maturation was impaired. Interestingly, the regulation of Fyn mRNA and protein expression was also impaired in fibroblasts of patients deficient in glutathione synthesis. Thus, glutathione and redox regulation have a critical role in myelination processes and white matter maturation in the prefrontal cortex of rodent and human, a mechanism potentially disrupted in schizophrenia.

Citing Articles

The Genomic Intersection of Oligodendrocyte Dynamics in Schizophrenia and Aging Unravels Novel Pathological Mechanisms and Therapeutic Potentials.

Rivera A, Normanton J, Butt A, Azim K Int J Mol Sci. 2024; 25(8).

PMID: 38674040 PMC: 11050044. DOI: 10.3390/ijms25084452.


Positive Effects of Uric Acid on White Matter Microstructures and Treatment Response in Patients With Schizophrenia.

Bang M, Heo Y, Choi T, Lee S Schizophr Bull. 2024; 50(4):815-826.

PMID: 38300803 PMC: 11283201. DOI: 10.1093/schbul/sbae008.


Sex-specific interactions between stress axis and redox balance are associated with internalizing symptoms and brain white matter microstructure in adolescents.

Schilliger Z, Aleman-Gomez Y, Smith M, Celen Z, Meuleman B, Binz P Transl Psychiatry. 2024; 14(1):30.

PMID: 38233401 PMC: 10794182. DOI: 10.1038/s41398-023-02728-4.


Schizophrenia and Glutathione: A Challenging Story.

Carletti B, Banaj N, Piras F, Bossu P J Pers Med. 2023; 13(11).

PMID: 38003841 PMC: 10672475. DOI: 10.3390/jpm13111526.


Developmental changes in cerebral NAD and neuroenergetics of an antioxidant compromised mouse model of schizophrenia.

Skupienski R, Steullet P, Do K, Xin L Transl Psychiatry. 2023; 13(1):275.

PMID: 37543592 PMC: 10404265. DOI: 10.1038/s41398-023-02568-2.


References
1.
Kulak A, Cuenod M, Do K . Behavioral phenotyping of glutathione-deficient mice: relevance to schizophrenia and bipolar disorder. Behav Brain Res. 2011; 226(2):563-70. DOI: 10.1016/j.bbr.2011.10.020. View

2.
Matsuzawa D, Hashimoto K . Magnetic resonance spectroscopy study of the antioxidant defense system in schizophrenia. Antioxid Redox Signal. 2010; 15(7):2057-65. DOI: 10.1089/ars.2010.3453. View

3.
Steullet P, Cabungcal J, Kulak A, Kraftsik R, Chen Y, Dalton T . Redox dysregulation affects the ventral but not dorsal hippocampus: impairment of parvalbumin neurons, gamma oscillations, and related behaviors. J Neurosci. 2010; 30(7):2547-58. PMC: 6634545. DOI: 10.1523/JNEUROSCI.3857-09.2010. View

4.
Kolb B, Mychasiuk R, Muhammad A, Li Y, Frost D, Gibb R . Experience and the developing prefrontal cortex. Proc Natl Acad Sci U S A. 2012; 109 Suppl 2:17186-93. PMC: 3477383. DOI: 10.1073/pnas.1121251109. View

5.
Yao J, Keshavan M . Antioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view. Antioxid Redox Signal. 2010; 15(7):2011-35. PMC: 3159108. DOI: 10.1089/ars.2010.3603. View